The genetic landscape of urologic cancers has evolved with the identification of actionable mutations that impact diagnosis, prognosis, and therapeutic strategies. This narrative review consolidates existing literature on genetic mutations across key urologic cancers, including bladder, renal, prostate, upper tract urothelial, testicular, and penile. The review highlights mutations in DNA damage repair genes, such as BRCA1/2 and PTEN, as well as pathway alterations like FGFR and PD-L1 overexpression. These mutations influence tumor behavior and therapeutic outcomes, emphasizing the need for precision oncology approaches. Molecular profiling, through tools like next-generation sequencing, has revolutionized patient care by enabling targeted treatment strategies, especially in cancers with distinct molecular subtypes such as luminal or basal bladder cancer and clear cell renal carcinoma. Emerging therapies, including FGFR inhibitors and immune checkpoint blockade, offer new treatment avenues, although resistance mechanisms remain a challenge. We also emphasize the importance of biomarker identification for personalized management, especially in metastatic settings where treatment intensification is often required. Future research is needed to further elucidate our understanding of the genetics affecting urologic cancers, which will help develop novel, individualized therapies to enhance oncologic outcomes.
1 May 2026 in Journal of Vascular Surgery Cases, Innovations and Techniques
Fenestrated endovascular aneurysm repair (FEVAR) has become a preferred approach for complex aortic pathology involving the visceral vessels, particularly in patients at high risk for open repair. Tuberculosis aortitis is rare, with few documented cases involving the visceral aorta. This case report describes a 68-year-old man with a history of bladder cancer undergoing immunotherapy who developed penetrating aortic ulcers secondary to suspected tuberculosis aortitis and underwent successful laser FEVAR. This case highlights the feasibility and efficacy of laser FEVAR for complex aortic disease such as tuberculosis aortitis and demonstrates its role as a life-saving strategy in high-risk patients.